# Alzamend Neuro, Inc.: Form 8-K, filed Dec 12, 2024

- Company: [Alzamend Neuro, Inc.](/companies/alzn.md) (CIK 1677077)
- Form: 8-K
- Filed: 2024-12-12
- Accepted by EDGAR: Dec 12, 2024, 21:30 ET
- Period: 2024-12-12
- Accession: 0001214659-24-020439
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1677077/000121465924020439/d12122438k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1677077/000121465924020439/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1677077/000121465924020439/d12122438k.htm

Filed Dec 12, 2024.
Source: SEC EDGAR, the filing index for accession 0001214659-24-020439. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.